Arcellx (ACLX) Change in Accured Expenses (2021 - 2025)

Arcellx's quarterly Change in Accured Expenses came in at $958000.0 in Q4 2025, down 97.51% year-on-year from $38.5 million in Q4 2024, and down 45.35% quarter-over-quarter from $1.8 million in Q3 2025.

Arcellx has reported Change in Accured Expenses for 5 years, with the latest figure at $958000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Change in Accured Expenses fell 97.51% year-over-year to $958000.0; the trailing twelve-month figure through Dec 2025 stood at $2.7 million (down 93.66% YoY), and the FY2025 full-year result was $2.7 million, down 93.66% from the prior year.
  • Change in Accured Expenses for Q4 2025 stood at $958000.0, down from $1.8 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $38.5 million in Q4 2024, with the low at -$23.2 million in Q3 2024.
  • Average Change in Accured Expenses over 5 years is $2.9 million, with a median of $1.1 million recorded in 2021.
  • Year-over-year, Change in Accured Expenses plunged 2165.78% in 2023 and jumped 1946.36% in 2024.
  • Tracing ACLX's Change in Accured Expenses over 5 years: stood at $1.3 million in 2021, then tumbled by 248.74% to -$1.9 million in 2022, then jumped by 483.32% to $7.2 million in 2023, then jumped by 431.63% to $38.5 million in 2024, then slumped by 97.51% to $958000.0 in 2025.
  • The last three Change in Accured Expenses figures came in at $958000.0 (Q4 2025), $1.8 million (Q3 2025), and -$2.3 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 958,000.00

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 958,000.00
Dec 31, 2025 958,000.00
Sep 30, 2025 1.75 Mn
Sep 30, 2025 1.75 Mn
Jun 30, 2025 -2.29 Mn
Jun 30, 2025 -2.29 Mn
Mar 31, 2025 2.24 Mn
Mar 31, 2025 2.24 Mn
Dec 31, 2024 38.50 Mn
Dec 31, 2024 38.50 Mn
Sep 30, 2024 -23.17 Mn
Sep 30, 2024 -23.17 Mn
Jun 30, 2024 9.00 Mn
Jun 30, 2024 9.00 Mn
Mar 31, 2024 17.68 Mn
Mar 31, 2024 17.68 Mn
Dec 31, 2023 7.24 Mn
Dec 31, 2023 7.24 Mn
Sep 30, 2023 2.15 Mn
Sep 30, 2023 2.15 Mn
Jun 30, 2023 440,000.00
Jun 30, 2023 440,000.00
Mar 31, 2023 -4.24 Mn
Mar 31, 2023 -4.24 Mn
Dec 31, 2022 -1.89 Mn
Dec 31, 2022 -1.89 Mn
Sep 30, 2022 -4.17 Mn
Sep 30, 2022 -4.17 Mn
Jun 30, 2022 5.85 Mn
Jun 30, 2022 5.85 Mn
Mar 31, 2022 -187,000.00
Mar 31, 2022 -187,000.00
Dec 31, 2021 1.27 Mn
Dec 31, 2021 1.27 Mn
Sep 30, 2021 5.49 Mn
Sep 30, 2021 5.49 Mn
Jun 30, 2021 679,000.00
Jun 30, 2021 679,000.00
Mar 31, 2021 321,000.00
Mar 31, 2021 321,000.00